Cancer is a disease caused by genomic changes in the cells of our body. These changes, called mutations, can be harmful, beneficial, or have no effect. Harmful mutations can cause normal cells to grow and divide uncontrollably, leading to cancer.
Genomic profiling sheds light on the combination of mutations that makes each patient’s cancer unique. This information can be used to personalize treatment for every patient.
LiquidHALLMARK® provides Swift , Simple and Sensitive Genomic Profiling
Genomic testing provides additional information to your provider that helps to personalize treatment according to your tumor’s genomic profile. Your genomic profile can also be used to match you to suitable clinical trials where new medicines are being developed, as well as track mutation changes in your tumor.
LiquidHALLMARK is a liquid biopsy genomic test that reveals important information about a tumor from a single blood draw. This information is what is known as a tumor’s genomic profile. LiquidHALLMARK provides your doctor with information to develop a personalized treatment plan at the time of diagnosis based on your tumor genomic profile. Testing can also be utilized to monitor your treatment response and/or changes within a tumor.
We are committed to improving access to affordable testing. LiquidHALLMARK® provides important information for your cancer care and personalized treatment. Cost should not be in the way of you and the right treatment.
If you have questions or require more information regarding your LiquidHALLMARK® test or billing, contact our Patient Excellence Team at 888-582-3623 or [email protected].